31![Federal Register / Vol. 80, No[removed]Tuesday, March 31, [removed]Notices The Food and Drug Administration (FDA) is announcing a request for additional comments on the chemistry, manufacturing, and control (CMC) information Federal Register / Vol. 80, No[removed]Tuesday, March 31, [removed]Notices The Food and Drug Administration (FDA) is announcing a request for additional comments on the chemistry, manufacturing, and control (CMC) information](https://www.pdfsearch.io/img/7326f6b00ddf55ebf25226d9de3736a5.jpg) | Add to Reading ListSource URL: www.gpo.govLanguage: English - Date: 2015-03-31 08:02:18
|
---|
32![Patient‐Focused Drug Development Public Meeting Public Meeting Theresa M. Mullin, Ph.D. Associate Director for Planning and Informatics FDA Center for Drug Evaluation and Research Patient‐Focused Drug Development Public Meeting Public Meeting Theresa M. Mullin, Ph.D. Associate Director for Planning and Informatics FDA Center for Drug Evaluation and Research](https://www.pdfsearch.io/img/ac8f1aa9c17e5366b839a4f15d644466.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
33![7616 Federal Register / Vol. 80, No[removed]Wednesday, February 11, [removed]Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES 7616 Federal Register / Vol. 80, No[removed]Wednesday, February 11, [removed]Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://www.pdfsearch.io/img/6ad14432251c3b9af29748ff1a569fc0.jpg) | Add to Reading ListSource URL: www.gpo.govLanguage: English - Date: 2015-02-11 10:21:40
|
---|
34![Capital Reporting Company FDA -- Meta-Analysis Guidance[removed]1 CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) Capital Reporting Company FDA -- Meta-Analysis Guidance[removed]1 CENTER FOR DRUG EVALUATION AND RESEARCH (CDER)](https://www.pdfsearch.io/img/fac8fffe1e844a3acd98ae8d5815762f.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
35![FY 2015 FDA Operating Plan FY 2015 FDA Operating Plan](https://www.pdfsearch.io/img/3fcf4c34fc308395b0ec06a70cc33512.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
36![Microsoft Word - 16618dft.doc Microsoft Word - 16618dft.doc](https://www.pdfsearch.io/img/869fa50b5391b3935b444f79f090e9aa.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
37![Microsoft Word[removed]doc Microsoft Word[removed]doc](https://www.pdfsearch.io/img/82fd866e6bb158141d7746d3f4f3f82d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
38![[removed]Federal Register / Vol. 69, No[removed]Tuesday, September 28, [removed]Notices ‘‘Guidance for Industry: Animal Drug Sponsor Fees Under the Animal Drug [removed]Federal Register / Vol. 69, No[removed]Tuesday, September 28, [removed]Notices ‘‘Guidance for Industry: Animal Drug Sponsor Fees Under the Animal Drug](https://www.pdfsearch.io/img/5efa331df6a23c4306bd2ea0ab1255c0.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
39![Non-Clinical Cardiovascular Safety Testing: Moving Forward Non-Clinical Cardiovascular Safety Testing: Moving Forward](https://www.pdfsearch.io/img/c20a369c11366f9f621a1148c1a5671a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
40![Overview of FDA Support for Innovation Overview of FDA Support for Innovation](https://www.pdfsearch.io/img/0b98fb76d5ce72b4609197521ab7316a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|